Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
West Michigan Cancer Center & Institute for Blood Disorders (WMCC) is a comprehensive outpatient cancer center located in Kalamazoo, Michigan. Founded in 1994 as a joint venture between Ascension Borgess and Bronson Healthcare, it serves as a regional hub for advanced oncology and hematology services. The center provides a wide array of treatments, including radiation oncology, medical oncology, and gynecologic oncology, alongside specialized blood disorder care. WMCC is heavily involved in clinical research, participating in numerous national clinical trials to provide patients with access to emerging therapies. Its multidisciplinary team utilizes state-of-the-art technology, such as advanced linear accelerators and radiosurgery systems, to deliver personalized patient care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on West Michigan Cancer Center.